ISRCTN45782014已完成不适用
Oral hydroxycitric acid (HCA) supplementation enhances glycogen synthesis in exercised human skeletal 1 muscle: a randomised placebo-controlled cross-over trial
ational Science Council (Taiwan)0 个研究点目标入组 8 人开始时间: 2011年1月21日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •1. Healthy male volunteers
- •2. Aged 22.0 +/- 0.3 years
- •3. Height 171.3 +/- 0.7 cm
- •4. Weight 73.7 +/- 1.1 kg
- •5. Body mass index (BMI) 25.2 +/- 0.5 kg/m2
- •6. Ventilatory equivalent for oxygen (VEO2) 108
- •7. Peak 45.7 +/- 1.5 ml/kg/min
排除标准
- •Male volunteer's VO2max less than 30 ml/kg/min
研究者
相似试验
进行中（未招募）
不适用
Oral Hyaluronic Acid Supplementation for the Treatment of Dry Eye DiseaseKCT0004231Soon Chun Hyang University Hospital Bucheon24
已完成
不适用
Clinical Study to Evaluate the Anti-aging Efficacy of Dermial®Skin AgingNCT05813054Bioiberica60
已完成
不适用
Efficacy and safety of hydroxocobalamin acetate in patients with taxane-induced sensory peripheral neuropathy A multi-center, observational study(HAPPY study)sensory peripheral neuropathyJPRN-UMIN000022292Research hospital, the Institute of Medical Science,the University of Tokyo20
已完成
1 期
Phase I/II trial of oral hydroxyurea in combination with pegylated interferon and ribavirin in chronic hepatitis C patientsChronic hepatitis CJPRN-UMIN000003457Yokohama City University Medical Center Gastroenterological Center20
进行中（未招募）
1 期
CHLOROQUINE FOR PREVENTION OF ABNORMAL GLUCOSE TOLERANCE AND DIABETES IN INDIVIDUALS AT-RISK FOR TYPE 1 DIABETES MELLITUSEUCTR2018-000659-42-GBTrialNet Coordinating Center201